Acumen Pharmaceuticals Inc. (ABOS): Narxning sotuvga nisbati
Narx/savdo koeffitsienti Acumen Pharmaceuticals (ABOS) kompaniyasining bozor qiymati dinamikasini aks ettiradi, bunda ushbu ko'rsatkichning joriy qiymatidir. Acumen Pharmaceuticals o'zining maqsadli antitana uchun kengaytirish rejasini amalga oshirmoqda va uning samaradorligini tasdiqlamoqda. II bosqich sinovlaridagi muvaffaqiyatlar va sanoat gigantlari tomonidan sotib olinish ehtimoli aksiyalar o'sishini rag'batlantirmoqda. Terapiyaning muvaffaqiyati Altsgeymer kasalligi davolashiga bo'lgan ulkan talab tufayli istisno darajadagi narx belgilash imkoniyatini ta'minlaydi.
%20P%2FS%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_ABOS_-_Acumen-Pharmaceuticals_-_PS-Multiple "ABOS - Acumen Pharmaceuticals, Inc Bozor kapitallashuvining daromadga nisbati 04.07.2022 - 13.11.2026 oraligʻida | 👁️GURU.Markets👁️")
Acumen Pharma (ABOS) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Barcha qarzlarning o‘z mablag‘lariga nisbati Acumen Pharmaceuticals|ABOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Acumen Pharmaceuticals, Inc|ABOS - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Acumen Pharma|ABOS - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Acumen Pharmaceuticals|Shoshilinch likvidlik acumenpharm.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
ABOS - Sof daromad|Prognoz qilingan kelajakdagi foyda Acumen Pharmaceuticals|ABOS - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati Acumen Pharmaceuticals Inc.|ABOS - PEG multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Acumen Pharma|ABOS - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun sof foyda Acumen Pharmaceuticals|ABOS - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi acumenpharm.com|ABOS - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Acumen Pharmaceuticals
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:ABOS acumenpharm.com
Neyrobiologlarning intellektual kapitali va klinik ekspertlar shtatining kengayishi Acumen Pharmaceuticals (ABOS) qiymatining asosiy poydevorini tashkil etadi. Ushbu resurslarning dinamikasi bozor kutganlarini aks ettiruvchi narx-savdo koeffitsiyentida namoyon bo'ladi. Ushbu metrika bozor kapitalizatsiyasini savdo hajmi bilan solishtirib, aktivlar baholanishi va haqiqiy daromadlar o'rtasidagi nomutanosiblikni ochib beradi. Ko'rsatkichning pasayishi aktivlarning qadrsizlanganidan dalolat berishi mumkin, jabda keskin ko'tarilish baholashning haddan tashqari oshganligi haqida ogohlantiradi.
Raqobatdosh kompaniyalar
BIIB (biogen.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Neurocrine Biosciences, Inc. NBIX|RGC (Regencell Bioscience Ltd) - Narxning sotuvga nisbati|Axsome Therapeutics Inc - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Corp)|XENE: P/S multiplikatori|vikingtherapeutics.com (VKTX) - P/S multiplikatori|Narxning daromadga nisbati Supernus|CPRX: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Denali Therapeutics Inc (DNLI)|Kapitalizatsiyaning daromadga nisbati Harmony Corp HRMY|P/S multiplikatori BHVN (Biohaven Ltd.)|P/S multiplikatori amylyx.com AMLX|Trevi Therapeutics, Inc. - P/S multiplikatori|Praxis Precision Medicines Inc (PRAX) - Kapitalizatsiyaning daromadga nisbati|AVXL: P/S multiplikatori|Sotuvga nisbatan narx CeriBell EEG (CBLL)|Kapitalizatsiyaning daromadga nisbati PRTA|P/S multiplikatori Alector Therapeutics|Kapitalizatsiyaning daromadga nisbati ANNX (Annexon)|Kapitalizatsiyaning sotish hajmiga nisbati OMER|P/S multiplikatori NGNE (Neurogene Corp)|Narx/daromad koeffitsiyenti AC Immune Inc (ACIU)|Voyager Therapeutics - P/S multiplikatori|neumoratx.com (NMRA) - Kapitalizatsiyaning daromadga nisbati|SCLX: P/S multiplikatori|Tevogen Bio Holdings Inc. (TVGN) - P/S multiplikatori|Narxning daromadga nisbati Alpha Cognition Inc|Narxning daromadga nisbati CGTX|Narxning daromadga nisbati Inhibikase Therapeutics (IKT)|Narx/daromad koeffitsiyenti cassavasciences.com|P/S multiplikatori ASRT (Assertio)|P/S multiplikatori Coya Therapeutics Inc COYA|VistaGen Therapeutics Inc - P/S multiplikatori|OVID: Narxning daromadga nisbati|CervoMed Inc. (CRVO) - Narxning daromadga nisbati|Sotuvga nisbatan narx Alterity Therapeutics Limited (ATHE)|Narxning daromadga nisbati Clene Inc|PepGen Corp (PEPG) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Jupiter Neurosciences (JUNS)|Relmada Corp - Kapitalizatsiya va daromad nisbati|P/S multiplikatori ANVS (Annovis Bio, Inc.)|Grace Therapeutics Inc (GRCE) - Sotuvga nisbatan narx|AIFF: Kapitalizatsiyaning daromadga nisbati|KLTO - P/S multiplikatori|neurosense-tx.com (NRSN) - Narxning daromadga nisbati|Reviva Pharmaceuticals, Inc. - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati MetaVia Inc.|Sotuvga nisbatan narx neuraxis.com NRXS|P/S multiplikatori HSDT|P/S multiplikatori passagebio.com (PASG)|P/S multiplikatori NEUP (Neuphoria Therapeutics)|NERV - Kapitalizatsiyaning daromadga nisbati|ATHA: Kapitalizatsiyaning daromadga nisbati|ADXN - P/S multiplikatori|alzamend.com (ALZN) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Cyclerion Therapeutics, Inc.|PTIX (Protagenic Therapeutics Inc.) - P/S multiplikatori|Sotuvga nisbatan narx Pasithea KTTA|Narxning daromadga nisbati Cortigent, Inc. (CRGT)|avenuetx.com - Kapitalizatsiya va daromad nisbati|BrainStorm Cell Therapeutics - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati CARA|CHRO - Narxning daromadga nisbati|Narxning sotuvga nisbati ELYM|ITCI: P/S multiplikatori|longboardpharma.com - Bozor kapitallashuvining daromadga nisbati|MRNS (Marinus Pharmaceuticals, Inc.) - P/S multiplikatori|P/S multiplikatori NKGen Biotech Inc|Narxning daromadga nisbati NeuroBo (NRBO)|SAGE (Sage Therapeutics Inc) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Synaptogenix, Inc. SNPX|TRVN - Kapitalizatsiyaning daromadga nisbati|Vigil Neuro - P/S multiplikatori|WENA - P/S multiplikatori|CERE: P/S multiplikatori
